PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: B3C Communications

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

B3C Newswire Launches Biotech News App for iPhone and Android - B3C Group, operating B3C newswire, the press release distribution service with the largest reach in biotech trade media, today announced that it has launched a highly customizable news app for biotech press releases - B3Cnewswire.com
B3C Newswire Launches Biotech News App for iPhone and Android

 

NewswireToday - /newswire/ - Traunstein, Switzerland, 2011/06/20 - B3C Group, operating B3C newswire, the press release distribution service with the largest reach in biotech trade media, today announced that it has launched a highly customizable news app for biotech press releases - B3Cnewswire.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

B3C Group, operating B3C newswire, the press release distribution service with the largest reach in biotech trade media, today announced that it has launched a highly customizable news app for biotech press releases. With B3C newswire app users can pick from pre-selected biotech news feeds or easily add feeds from favorite websites to catch up with breaking news in the biotech industry anytime and anywhere. In addition, all press releases distributed by B3C newswire show up in the app. The app is available at no cost for the iPhone, iPod touch and Android platforms. A BlackBerry version will follow soon. Download links for the app are available here.

“In time for BIO 2011, B3C newswire app provides editors and delegates of biotech companies attending the show instant access to industry-specific news using their mobile devices,” says Sabine Duntze, CEO of B3C Group. “The app complements our targeted PR distribution strategy that now encompasses print, online, social and mobile channels.”

About B3C newswire

B3C newswire (b3cnewswire.com) is the first PR distribution service completely dedicated to biotech that provides the largest reach in biotech, pharmaceutical, medical devices and diagnostics trade media worldwide. B3C newswire maintains a huge list of mostly personal E: addresses of editors. Many of them have specified the news topics they are interested in which means that press releases have a better chance of being used. B3C currently provides 22 specialized channels and tweets each news release using a large biotech-specific Twitter network. Additionally, B3C newswire pro-actively posts news releases to social media to reach 250,000+ biotech professionals. B3C newswire is a service provided by B3C Group GmbH, located in Eich-Lucerne, Switzerland.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: B3C Communications

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


B3C Newswire Launches Biotech News App for iPhone and Android

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Sabine Duntze - B3C.de 
+49 8619098220 info[.]b3cgroup.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any B3C Communications securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From B3C Communications / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience
Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care
BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)